e-learning
resources
Munich 2014
Monday, 08.09.2014
Tuberculosis: from epidemiology to therapy 2
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lag period for diagnosing and starting treatment for pulmonary tuberculosis patients
D. Madegedara, D. Nandadeva, S. Dhanasekera, H. Kumara (Kandy, Sri Lanka)
Source:
International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Session:
Tuberculosis: from epidemiology to therapy 2
Session type:
Thematic Poster Session
Number:
2674
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Madegedara, D. Nandadeva, S. Dhanasekera, H. Kumara (Kandy, Sri Lanka). Lag period for diagnosing and starting treatment for pulmonary tuberculosis patients. Eur Respir J 2014; 44: Suppl. 58, 2674
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
MOTT as a cause of treatment failure in pulmonary tuberculosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
Link between clinical severity of osteoarticular tuberculosis and the combined presence of pulmonary tuberculosis
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016
Predictive factors of recurrent pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
The feature of BCG complications in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
How long do patients with pulmonary tuberculosis remain smear and culture positive?
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013
Active tuberculosis prevalence and characteristics of tuberculosis patients in liver transplant patients
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
Immunodiagnosis of tuberculosis infection in children under the age of five - Which testing is feasible?
Source: International Congress 2015 – Paediatric bronchology
Year: 2015
Side effects of chemical preparations in patients with drug-resistant pulmonary tuberculosis
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015
The risk of tuberculosis in HIV infected in the 12 years of observation
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
Experience of using diaskintest in adult patients with tuberculosis and non-tuberculosis respiratory diseases in a regional TB hospital
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Immune response in children with latent tuberculosis infection and active pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Acute phase reaction in pulmonary tuberculosis during treatment
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
Features of pulmonary tuberculosis in migrants
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
Risk factors for disseminated tuberculosis
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Detection of tuberculosis in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
Extrapulmonary tuberculosis in HIV infected patients admitted to the hospital
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016
Features detection of tuberculosis in HIV-patients in the region with a high prevalence of tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
Pulmonary tuberculosis in the elderly: A series of 163 cases
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Clinical progression of tuberculosis in children with HIV-infection
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Significance of contacts in the manifestation of tuberculosis as an infectious disease
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept